{"id":"https://openalex.org/W4409175136","doi":"https://doi.org/10.1038/s41598-025-94317-2","title":"A high-throughput, fully automated competition assay to evaluate SARS-CoV-2 neutralizing responses and epitope specificity in clinical samples","display_name":"A high-throughput, fully automated competition assay to evaluate SARS-CoV-2 neutralizing responses and epitope specificity in clinical samples","publication_year":2025,"publication_date":"2025-04-04","ids":{"openalex":"https://openalex.org/W4409175136","doi":"https://doi.org/10.1038/s41598-025-94317-2","pmid":"https://pubmed.ncbi.nlm.nih.gov/40185856","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/11971398"},"language":"en","primary_location":{"id":"doi:10.1038/s41598-025-94317-2","doi":"https://doi.org/10.1038/s41598-025-94317-2","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41598-025-94317-2","pdf_url":"https://www.nature.com/articles/s41598-025-94317-2.pdf","source":{"id":"https://openalex.org/S196734849","display_name":"Scientific Reports","issn_l":"2045-2322","issn":["2045-2322"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific Reports","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.nature.com/articles/s41598-025-94317-2.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062111046","display_name":"Yusuke Atarashi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I54594937","display_name":"Sysmex (Japan)","ror":"https://ror.org/00gfstq19","country_code":"JP","type":"company","lineage":["https://openalex.org/I54594937"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yusuke Atarashi","raw_affiliation_strings":["Central Research Laboratories, Sysmex Corporation, Kobe, 651-2271, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Research Laboratories, Sysmex Corporation, Kobe, 651-2271, Japan","institution_ids":["https://openalex.org/I54594937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032544422","display_name":"Jeeeun Kim","orcid":"https://orcid.org/0000-0002-8915-481X","observed_orcids":["https://orcid.org/0000-0002-8915-481X"]},"institutions":[{"id":"https://openalex.org/I54594937","display_name":"Sysmex (Japan)","ror":"https://ror.org/00gfstq19","country_code":"JP","type":"company","lineage":["https://openalex.org/I54594937"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Jeeeun Kim","raw_affiliation_strings":["Central Research Laboratories, Sysmex Corporation, Kobe, 651-2271, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Research Laboratories, Sysmex Corporation, Kobe, 651-2271, Japan","institution_ids":["https://openalex.org/I54594937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009771930","display_name":"Yasuhiro Irino","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I54594937","display_name":"Sysmex (Japan)","ror":"https://ror.org/00gfstq19","country_code":"JP","type":"company","lineage":["https://openalex.org/I54594937"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasuhiro Irino","raw_affiliation_strings":["Central Research Laboratories, Sysmex Corporation, Kobe, 651-2271, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Research Laboratories, Sysmex Corporation, Kobe, 651-2271, Japan","institution_ids":["https://openalex.org/I54594937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078649269","display_name":"Masayuki Amano","orcid":"https://orcid.org/0000-0003-0516-9502","observed_orcids":["https://orcid.org/0000-0003-0516-9502"]},"institutions":[{"id":"https://openalex.org/I4405285757","display_name":"Joint Research Center for Human Retrovirus Infection, Kumamoto University","ror":"https://ror.org/0059h2t89","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4405285757","https://openalex.org/I96036126"]},{"id":"https://openalex.org/I96036126","display_name":"Kumamoto University","ror":"https://ror.org/02cgss904","country_code":"JP","type":"education","lineage":["https://openalex.org/I96036126"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masayuki Amano","raw_affiliation_strings":["Department of Clinical Retrovirology, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, 860-8556, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Retrovirology, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto, 860-8556, Japan","institution_ids":["https://openalex.org/I4405285757","https://openalex.org/I96036126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037218495","display_name":"K. Tsuchiya","orcid":"https://orcid.org/0000-0002-8233-6653","observed_orcids":["https://orcid.org/0000-0002-8233-6653","https://orcid.org/0009-0007-8369-8588"]},"institutions":[{"id":"https://openalex.org/I4210094012","display_name":"National Center for Global Health and Medicine","ror":"https://ror.org/00r9w3j27","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210094012"]},{"id":"https://openalex.org/I4405284588","display_name":"Center Hospital of National Center for Global Health and Medicine","ror":"https://ror.org/03tyftx38","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I1333985979","https://openalex.org/I4210094012","https://openalex.org/I4405284588","https://openalex.org/I4405286871"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kiyoto Tsuchiya","raw_affiliation_strings":["AIDS Clinical Center, Center hospital of the National Center for Global Health and Medicine, Tokyo, 162-8655, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AIDS Clinical Center, Center hospital of the National Center for Global Health and Medicine, Tokyo, 162-8655, Japan","institution_ids":["https://openalex.org/I4210094012","https://openalex.org/I4405284588"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055989025","display_name":"Kenji Maeda","orcid":"https://orcid.org/0000-0002-9424-1491","observed_orcids":["https://orcid.org/0000-0002-9424-1491"]},"institutions":[{"id":"https://openalex.org/I107139324","display_name":"Kagoshima University","ror":"https://ror.org/03ss88z23","country_code":"JP","type":"education","lineage":["https://openalex.org/I107139324"]},{"id":"https://openalex.org/I4210094012","display_name":"National Center for Global Health and Medicine","ror":"https://ror.org/00r9w3j27","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210094012"]},{"id":"https://openalex.org/I4405286908","display_name":"Joint Research Center for Human Retrovirus Infection, Kagoshima University","ror":"https://ror.org/03gv4pa48","country_code":"JP","type":"facility","lineage":["https://openalex.org/I107139324","https://openalex.org/I4405286908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kenji Maeda","raw_affiliation_strings":["Division of Antiviral Therapy, Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, Japan, 890-8544","Refractory Viral Diseases, National Center for Global Health and Medicine Research Institute, Tokyo, 162-8655, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Antiviral Therapy, Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, Japan, 890-8544","institution_ids":["https://openalex.org/I107139324","https://openalex.org/I4405286908"]},{"raw_affiliation_string":"Refractory Viral Diseases, National Center for Global Health and Medicine Research Institute, Tokyo, 162-8655, Japan","institution_ids":["https://openalex.org/I4210094012"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057845283","display_name":"Mari Terada","orcid":"https://orcid.org/0000-0002-5171-1828","observed_orcids":["https://orcid.org/0000-0002-5171-1828"]},"institutions":[{"id":"https://openalex.org/I4210094012","display_name":"National Center for Global Health and Medicine","ror":"https://ror.org/00r9w3j27","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210094012"]},{"id":"https://openalex.org/I4405284588","display_name":"Center Hospital of National Center for Global Health and Medicine","ror":"https://ror.org/03tyftx38","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I1333985979","https://openalex.org/I4210094012","https://openalex.org/I4405284588","https://openalex.org/I4405286871"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mari Terada","raw_affiliation_strings":["Department of Disease Control Center, Center Hospital of the National Center for Global Health and Medicine, Tokyo, 162-8655, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Disease Control Center, Center Hospital of the National Center for Global Health and Medicine, Tokyo, 162-8655, Japan","institution_ids":["https://openalex.org/I4210094012","https://openalex.org/I4405284588"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012161779","display_name":"Noriko Iwamoto","orcid":"https://orcid.org/0000-0001-5471-7363","observed_orcids":["https://orcid.org/0000-0001-5471-7363"]},"institutions":[{"id":"https://openalex.org/I4210094012","display_name":"National Center for Global Health and Medicine","ror":"https://ror.org/00r9w3j27","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210094012"]},{"id":"https://openalex.org/I4405284588","display_name":"Center Hospital of National Center for Global Health and Medicine","ror":"https://ror.org/03tyftx38","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I1333985979","https://openalex.org/I4210094012","https://openalex.org/I4405284588","https://openalex.org/I4405286871"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Noriko Iwamoto","raw_affiliation_strings":["Department of Disease Control Center, Center Hospital of the National Center for Global Health and Medicine, Tokyo, 162-8655, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Disease Control Center, Center Hospital of the National Center for Global Health and Medicine, Tokyo, 162-8655, Japan","institution_ids":["https://openalex.org/I4210094012","https://openalex.org/I4405284588"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082150793","display_name":"Shinya Shimada","orcid":"https://orcid.org/0000-0002-8719-0729","observed_orcids":["https://orcid.org/0000-0002-8719-0729"]},"institutions":[{"id":"https://openalex.org/I4210132540","display_name":"Japan Community Healthcare Organization","ror":"https://ror.org/03q11y497","country_code":"JP","type":"government","lineage":["https://openalex.org/I4210132540"]},{"id":"https://openalex.org/I4405285455","display_name":"Kumamoto General Hospital","ror":"https://ror.org/05g0dg369","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210132540","https://openalex.org/I4405285455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shinya Shimada","raw_affiliation_strings":["Japan Community Healthcare Organization, Kumamoto General Hospital, 866- 8660, Kumamoto, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Japan Community Healthcare Organization, Kumamoto General Hospital, 866- 8660, Kumamoto, Japan","institution_ids":["https://openalex.org/I4210132540","https://openalex.org/I4405285455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034448543","display_name":"Hiroaki Mitsuya","orcid":"https://orcid.org/0000-0001-9274-3853","observed_orcids":["https://orcid.org/0000-0001-9274-3853"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210094012","display_name":"National Center for Global Health and Medicine","ror":"https://ror.org/00r9w3j27","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210094012"]},{"id":"https://openalex.org/I4210122547","display_name":"Kumamoto University Hospital","ror":"https://ror.org/02vgs9327","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210122547"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["JP","US"],"is_corresponding":false,"raw_author_name":"Hiroaki Mitsuya","raw_affiliation_strings":["Division of Clinical Sciences, Kumamoto University Hospital, 860-8556, Kumamoto, Japan","Experimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, 20892-1868, Bethesda, MD, USA","Refractory Viral Diseases, National Center for Global Health and Medicine Research Institute, Tokyo, 162-8655, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Sciences, Kumamoto University Hospital, 860-8556, Kumamoto, Japan","institution_ids":["https://openalex.org/I4210122547"]},{"raw_affiliation_string":"Experimental Retrovirology Section, HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, 20892-1868, Bethesda, MD, USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"raw_affiliation_string":"Refractory Viral Diseases, National Center for Global Health and Medicine Research Institute, Tokyo, 162-8655, Japan","institution_ids":["https://openalex.org/I4210094012"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055037358","display_name":"Masatoshi Yanagida","orcid":"https://orcid.org/0000-0002-4407-8120","observed_orcids":["https://orcid.org/0000-0002-4407-8120"]},"institutions":[{"id":"https://openalex.org/I54594937","display_name":"Sysmex (Japan)","ror":"https://ror.org/00gfstq19","country_code":"JP","type":"company","lineage":["https://openalex.org/I54594937"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masatoshi Yanagida","raw_affiliation_strings":["Central Research Laboratories, Sysmex Corporation, Kobe, 651-2271, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Central Research Laboratories, Sysmex Corporation, Kobe, 651-2271, Japan","institution_ids":["https://openalex.org/I54594937"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5063881144","display_name":"Yuki Takamatsu","orcid":"https://orcid.org/0000-0001-7967-1576","observed_orcids":["https://orcid.org/0000-0001-7967-1576","https://orcid.org/0009-0008-6706-438X"]},"institutions":[{"id":"https://openalex.org/I4210094012","display_name":"National Center for Global Health and Medicine","ror":"https://ror.org/00r9w3j27","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210094012"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Yuki Takamatsu","raw_affiliation_strings":["Refractory Viral Diseases, National Center for Global Health and Medicine Research Institute, Tokyo, 162-8655, Japan. ytakamatsu@ri.ncgm.go.jp"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Refractory Viral Diseases, National Center for Global Health and Medicine Research Institute, Tokyo, 162-8655, Japan. ytakamatsu@ri.ncgm.go.jp","institution_ids":["https://openalex.org/I4210094012"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":12,"corresponding_author_ids":["https://openalex.org/A5063881144"],"corresponding_institution_ids":["https://openalex.org/I4210094012"],"apc_list":{"value":2690,"currency":"USD","value_usd":2690},"apc_paid":{"value":2690,"currency":"USD","value_usd":2690},"fwci":0.5947,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.57905791,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"15","issue":"1","first_page":"11589","last_page":"11589"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10118","display_name":"SARS-CoV-2 and COVID-19 Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11754","display_name":"SARS-CoV-2 detection and testing","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sars-cov-2","display_name":"SARS-CoV-2","score":0.9929999709129333},{"id":"https://openalex.org/keywords/covid-19","display_name":"COVID-19 pandemic","score":0.9390000104904175},{"id":"https://openalex.org/keywords/neutralizing-antibodies","display_name":"neutralizing antibodies","score":0.9679999947547913},{"id":"https://openalex.org/keywords/competitive-immunoassay","display_name":"competitive immunoassay","score":0.8840000033378601},{"id":"https://openalex.org/keywords/spike-receptor-binding-domain","display_name":"spike protein receptor-binding domain","score":0.8970000147819519},{"id":"https://openalex.org/keywords/receptor-binding-motif","display_name":"receptor-binding motif","score":0.953000009059906},{"id":"https://openalex.org/keywords/epitope-specificity","display_name":"epitope specificity","score":0.9259999990463257},{"id":"https://openalex.org/keywords/s1-subunit","display_name":"S1 subunit","score":0.8560000061988831},{"id":"https://openalex.org/keywords/vaccine-induced-immunity","display_name":"vaccine-induced immunity","score":0.5669999718666077},{"id":"https://openalex.org/keywords/natural-infection","display_name":"natural infection","score":0.9070000052452087},{"id":"https://openalex.org/keywords/antibody-titers","display_name":"antibody titers","score":0.7400000095367432},{"id":"https://openalex.org/keywords/diagnostic-antigen","display_name":"diagnostic antigen","score":0.7170000076293945}],"concepts":[{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.9013170003890991},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.7316727638244629},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.6620782613754272},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.5554288625717163},{"id":"https://openalex.org/C2780420688","wikidata":"https://www.wikidata.org/wiki/Q759183","display_name":"Immunoassay","level":3,"score":0.5197993516921997},{"id":"https://openalex.org/C2779261636","wikidata":"https://www.wikidata.org/wiki/Q7003054","display_name":"Neutralizing antibody","level":3,"score":0.5161129236221313},{"id":"https://openalex.org/C14086860","wikidata":"https://www.wikidata.org/wiki/Q337120","display_name":"Neutralization","level":3,"score":0.5107653141021729},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.4988977909088135},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.49700525403022766},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.494839608669281},{"id":"https://openalex.org/C2777648638","wikidata":"https://www.wikidata.org/wiki/Q57751738","display_name":"Coronavirus","level":5,"score":0.4796195924282074},{"id":"https://openalex.org/C2781241564","wikidata":"https://www.wikidata.org/wiki/Q1347450","display_name":"Epitope mapping","level":4,"score":0.44704583287239075},{"id":"https://openalex.org/C3007834351","wikidata":"https://www.wikidata.org/wiki/Q82069695","display_name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)","level":5,"score":0.4191851317882538},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2804046869277954},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.2470923364162445},{"id":"https://openalex.org/C3008058167","wikidata":"https://www.wikidata.org/wiki/Q84263196","display_name":"Coronavirus disease 2019 (COVID-19)","level":4,"score":0.24089717864990234},{"id":"https://openalex.org/C524204448","wikidata":"https://www.wikidata.org/wiki/Q788926","display_name":"Infectious disease (medical specialty)","level":3,"score":0.2036944031715393},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000086382","descriptor_name":"COVID-19","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":true},{"descriptor_ui":"D000086402","descriptor_name":"SARS-CoV-2","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000086663","descriptor_name":"COVID-19 Vaccines","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D000914","descriptor_name":"Antibodies, Viral","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D000914","descriptor_name":"Antibodies, Viral","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D000939","descriptor_name":"Epitopes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057134","descriptor_name":"Antibodies, Neutralizing","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D057134","descriptor_name":"Antibodies, Neutralizing","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D057166","descriptor_name":"High-Throughput Screening Assays","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D064370","descriptor_name":"Spike Glycoprotein, Coronavirus","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D064370","descriptor_name":"Spike Glycoprotein, Coronavirus","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1038/s41598-025-94317-2","doi":"https://doi.org/10.1038/s41598-025-94317-2","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41598-025-94317-2","pdf_url":"https://www.nature.com/articles/s41598-025-94317-2.pdf","source":{"id":"https://openalex.org/S196734849","display_name":"Scientific Reports","issn_l":"2045-2322","issn":["2045-2322"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific Reports","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:10783608","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11971398","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:40185856","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/40185856","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific reports","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:11971398","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11971398/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Sci Rep","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:1deb9dfa172c4ea088d48ecd837223e5","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/1deb9dfa172c4ea088d48ecd837223e5","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Scientific Reports, Vol 15, Iss 1, Pp 1-7 (2025)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1038/s41598-025-94317-2","doi":"https://doi.org/10.1038/s41598-025-94317-2","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41598-025-94317-2","pdf_url":"https://www.nature.com/articles/s41598-025-94317-2.pdf","source":{"id":"https://openalex.org/S196734849","display_name":"Scientific Reports","issn_l":"2045-2322","issn":["2045-2322"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific Reports","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G4791378500","display_name":"\u56de\u5fa9\u8005\u8840\u6f3f\u7642\u6cd5\u306b\u3088\u308bCOVID-19\u6cbb\u7642\u306e\u81e8\u5e8a\u958b\u767a\u3068\u30e9\u30f3\u30c0\u30e0\u5316\u6bd4\u8f03\u8a66\u9a13","funder_award_id":"20fk0108502h0001","funder_id":"https://openalex.org/F4320311405","funder_display_name":"Japan Agency for Medical Research and Development"},{"id":"https://openalex.org/G8500693620","display_name":null,"funder_award_id":"19A3001","funder_id":"https://openalex.org/F4320313449","funder_display_name":"National Center for Global Health and Medicine"}],"funders":[{"id":"https://openalex.org/F4320311405","display_name":"Japan Agency for Medical Research and Development","ror":"https://ror.org/004rtk039"},{"id":"https://openalex.org/F4320313449","display_name":"National Center for Global Health and Medicine","ror":"https://ror.org/00r9w3j27"},{"id":"https://openalex.org/F4320317814","display_name":"Sysmex Corporation","ror":"https://ror.org/00gfstq19"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4409175136.pdf","grobid_xml":"https://content.openalex.org/works/W4409175136.grobid-xml"},"referenced_works_count":28,"referenced_works":["https://openalex.org/W3012320055","https://openalex.org/W3017962953","https://openalex.org/W3034202401","https://openalex.org/W3045933491","https://openalex.org/W3108043937","https://openalex.org/W3111255098","https://openalex.org/W3111447240","https://openalex.org/W3113734454","https://openalex.org/W3117730334","https://openalex.org/W3131762051","https://openalex.org/W3133547117","https://openalex.org/W3135203780","https://openalex.org/W3164326780","https://openalex.org/W3172701548","https://openalex.org/W3201474993","https://openalex.org/W4205483821","https://openalex.org/W4213102925","https://openalex.org/W4220894677","https://openalex.org/W4280541438","https://openalex.org/W4292702020","https://openalex.org/W4297172779","https://openalex.org/W4311472757","https://openalex.org/W4317212025","https://openalex.org/W4317743572","https://openalex.org/W4362609000","https://openalex.org/W4389505247","https://openalex.org/W4389879789","https://openalex.org/W4390842173"],"related_works":["https://openalex.org/W4221045013","https://openalex.org/W3186476690","https://openalex.org/W3033295933","https://openalex.org/W4313454081","https://openalex.org/W4226087752","https://openalex.org/W4409266888","https://openalex.org/W3144503987","https://openalex.org/W3120940553","https://openalex.org/W3139029545","https://openalex.org/W3034680516"],"abstract_inverted_index":{"Coronavirus":[0],"disease-2019":[1],"(COVID-19)":[2],"remains":[3],"a":[4,11,84],"critical":[5,149],"global":[6],"health":[7],"concern.":[8],"We":[9],"developed":[10],"fully":[12],"automated,":[13],"high-throughput":[14],"competition":[15],"immunoassay":[16],"to":[17,63,119],"elucidate":[18],"how":[19],"epitope":[20],"recognition":[21],"on":[22],"the":[23,71,81,95,107,115,124],"severe":[24],"acute":[25],"respiratory":[26],"syndrome":[27],"coronavirus":[28],"2":[29],"(SARS-CoV-2)":[30],"spike":[31],"receptor-binding":[32,72],"domain":[33],"(RBD)":[34],"correlates":[35],"with":[36,98],"neutralizing":[37,99,145],"activity.":[38],"Analysis":[39],"of":[40,91,126,144],"clinical":[41],"samples":[42],"from":[43],"both":[44,78,127],"SARS-CoV-2-infected":[45],"and":[46,129,147,156],"vaccinated":[47],"individuals":[48],"revealed":[49],"that":[50,112],"vaccination":[51],"elicits":[52],"significantly":[53],"higher":[54],"antibody":[55,68,88],"titers":[56],"across":[57],"multiple":[58],"S1":[59,109],"subunit":[60],"epitopes":[61,113],"compared":[62],"natural":[64],"infection.":[65],"Notably,":[66],"median":[67],"levels":[69],"against":[70,106,136],"motif":[73],"(RBM)":[74],"exceeded":[75],"50%":[76],"in":[77,132],"cohorts,":[79],"highlighting":[80],"RBM":[82,116],"as":[83],"key":[85],"target":[86],"for":[87,103,151],"induction":[89],"irrespective":[90],"immune":[92,134,164],"origin.":[93],"Furthermore,":[94],"strongest":[96],"correlation":[97],"activity":[100],"was":[101],"observed":[102],"antibodies":[104,131,146],"directed":[105],"broader":[108],"subunit,":[110],"indicating":[111],"outside":[114],"also":[117],"contribute":[118],"neutralization.":[120],"These":[121],"findings":[122],"underscore":[123],"importance":[125],"RBM-":[128],"non-RBM-directed":[130],"effective":[133],"defense":[135],"SARS-CoV-2.":[137],"Our":[138],"assay":[139],"enables":[140],"large-scale,":[141],"reliable":[142],"quantification":[143],"provides":[148],"insights":[150],"developing":[152],"improved":[153],"diagnostic":[154],"antigens":[155],"vaccine":[157],"strategies":[158],"aimed":[159],"at":[160],"eliciting":[161],"robust,":[162],"multi-epitope":[163],"responses.":[165]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2025-04-05T00:00:00"}